Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 9.45
+0.04 (0.43%)
Mar 6, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 6.25 billion as of March 6, 2026. Its market cap has decreased by -7.89% in one year.
Market Cap
6.25B
Enterprise Value
8.75B
Revenue
1.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.45
Market Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has increased from 4.81B to 6.25B, an increase of 29.94%. That is a compound annual growth rate of 1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.25B | 3.85% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 7.18B |
| Jiangsu Aidea Pharmaceutical Group | 7.15B |
| Shenzhen Weiguang Biological Products | 6.57B |
| R&G PharmaStudies | 6.26B |
| Lifecome Biochemistry | 6.23B |
| Beijing Konruns Pharmaceutical | 6.22B |
| GemPharmatech | 6.05B |
| Shanghai OPM Biosciences | 5.92B |